| Rachel Amanda Harris, MD | |
|
3625 W 65th St Ste 100, Edina, MN 55435-2147 | |
| (952) 345-7070 | |
| (952) 345-0472 |
| Full Name | Rachel Amanda Harris |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 16 Years |
| Location | 3625 W 65th St Ste 100, Edina, Minnesota |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043486301 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 55072 (Minnesota) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Of Minnesota Medical Center, Fairview | Minneapolis, MN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Premier Obgyn Of Minnesota Pllc | 1355396110 | 70 |
News Archive
Excelitas Technologies® Corp., a global technology leader focused on delivering innovative, customized photonic solutions, today unveiled the new XLMii™ LED Fiber Optic Light Source for medical applications.
Orgenesis Inc., a leading cell and gene therapy enabling company providing centralized CDMO manufacturing and development services through its subsidiary Masthercell Global, Inc., as well as localized point-of-care development and processing centers for therapeutic treatments, today announces a strategic partnership agreement between the HYGEIA Group and the Theracell–Orgenesis joint venture.
Patients with larynx cancer who received a three-drug combination of docetaxel, cisplatin and 5-fluorouracil (TPF) during induction chemotherapy were more likely to retain larynx function than were patients treated with cisplatin and 5-fluoruracil (PF) alone, according to data from a randomized controlled trial in the March 24 online issue of the Journal of the National Cancer Institute.
Nine out of ten cases of tuberculosis appear in 30 identified low and middle-income countries, each of which has a national tuberculosis programme.
› Verified 8 days ago
| Entity Name | Premier Obgyn Of Minnesota Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801946223 PECOS PAC ID: 1355396110 Enrollment ID: O20050315000729 |
News Archive
Excelitas Technologies® Corp., a global technology leader focused on delivering innovative, customized photonic solutions, today unveiled the new XLMii™ LED Fiber Optic Light Source for medical applications.
Orgenesis Inc., a leading cell and gene therapy enabling company providing centralized CDMO manufacturing and development services through its subsidiary Masthercell Global, Inc., as well as localized point-of-care development and processing centers for therapeutic treatments, today announces a strategic partnership agreement between the HYGEIA Group and the Theracell–Orgenesis joint venture.
Patients with larynx cancer who received a three-drug combination of docetaxel, cisplatin and 5-fluorouracil (TPF) during induction chemotherapy were more likely to retain larynx function than were patients treated with cisplatin and 5-fluoruracil (PF) alone, according to data from a randomized controlled trial in the March 24 online issue of the Journal of the National Cancer Institute.
Nine out of ten cases of tuberculosis appear in 30 identified low and middle-income countries, each of which has a national tuberculosis programme.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Rachel Amanda Harris, MD 3625 W 65th St, Ste 100, Edina, MN 55435-2147 Ph: (952) 345-7070 | Rachel Amanda Harris, MD 3625 W 65th St Ste 100, Edina, MN 55435-2147 Ph: (952) 345-7070 |
News Archive
Excelitas Technologies® Corp., a global technology leader focused on delivering innovative, customized photonic solutions, today unveiled the new XLMii™ LED Fiber Optic Light Source for medical applications.
Orgenesis Inc., a leading cell and gene therapy enabling company providing centralized CDMO manufacturing and development services through its subsidiary Masthercell Global, Inc., as well as localized point-of-care development and processing centers for therapeutic treatments, today announces a strategic partnership agreement between the HYGEIA Group and the Theracell–Orgenesis joint venture.
Patients with larynx cancer who received a three-drug combination of docetaxel, cisplatin and 5-fluorouracil (TPF) during induction chemotherapy were more likely to retain larynx function than were patients treated with cisplatin and 5-fluoruracil (PF) alone, according to data from a randomized controlled trial in the March 24 online issue of the Journal of the National Cancer Institute.
Nine out of ten cases of tuberculosis appear in 30 identified low and middle-income countries, each of which has a national tuberculosis programme.
› Verified 8 days ago
Dr. April Batcheller, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 6565 France Ave S Ste 400, Edina, MN 55435 Phone: 952-225-1630 | |
Dr. Anne M Meschke, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3625 W 65th St, Suite 100, Edina, MN 55435 Phone: 952-920-7001 Fax: 952-920-2245 | |
Mackenzie Thayer, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 6405 France Ave S Ste W400, Edina, MN 55435 Phone: 952-920-2730 | |
Kimberly Anne Gerten, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 6565 France Ave S Ste 200, Edina, MN 55435 Phone: 952-920-2200 Fax: 952-920-0866 | |
Suzin Cho, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 6565 France Ave S, Suite 200, Edina, MN 55435 Phone: 952-920-2200 Fax: 952-920-0866 | |
Annelise S Swigert, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3625 W 65th St, Suite 100, Edina, MN 55435 Phone: 952-920-7001 Fax: 952-920-2245 |